Kaiser Permanente prior authorization criteria
Submission criteria, documentation packets, and P2P prep by drug — for prescribers and PA staff. 30-day standard PA decision.
Kaiser Permanente reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return in 30 days; if denied, prescribers and members have 180 days to appeal. Criteria by drug below.
Prior authorization criteria by drug
Each page covers Kaiser Permanente's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Kaiser Permanente →
- Aflibercept at Kaiser Permanente →
- Apixaban at Kaiser Permanente →
- Atezolizumab at Kaiser Permanente →
- Atogepant at Kaiser Permanente →
- Benralizumab at Kaiser Permanente →
- Bevacizumab at Kaiser Permanente →
- Bictegravir at Kaiser Permanente →
- Buprenorphine at Kaiser Permanente →
- Dapagliflozin at Kaiser Permanente →
- Dulaglutide at Kaiser Permanente →
- Dupilumab at Kaiser Permanente →
- Eculizumab at Kaiser Permanente →
- Elexacaftor Tezacaftor Ivacaftor at Kaiser Permanente →
- Empagliflozin at Kaiser Permanente →
- Erenumab at Kaiser Permanente →
- Evolocumab at Kaiser Permanente →
- Faricimab at Kaiser Permanente →
- Fingolimod at Kaiser Permanente →
- Fremanezumab at Kaiser Permanente →
- Galcanezumab at Kaiser Permanente →
- Glecaprevir Pibrentasvir at Kaiser Permanente →
- Guselkumab at Kaiser Permanente →
- Ibrutinib at Kaiser Permanente →
- Imatinib at Kaiser Permanente →
- Inclisiran at Kaiser Permanente →
- Infliximab at Kaiser Permanente →
- Ixekizumab at Kaiser Permanente →
- Lenalidomide at Kaiser Permanente →
- Liraglutide at Kaiser Permanente →
- Lisdexamfetamine at Kaiser Permanente →
- Mepolizumab at Kaiser Permanente →
- Methylphenidate at Kaiser Permanente →
- Naltrexone at Kaiser Permanente →
- Natalizumab at Kaiser Permanente →
- Nintedanib at Kaiser Permanente →
- Nivolumab at Kaiser Permanente →
- Nusinersen at Kaiser Permanente →
- Ocrelizumab at Kaiser Permanente →
- Ofatumumab at Kaiser Permanente →
- Omalizumab at Kaiser Permanente →
- Ozanimod at Kaiser Permanente →
- Palbociclib at Kaiser Permanente →
- Pembrolizumab at Kaiser Permanente →
- Pirfenidone at Kaiser Permanente →
- Ribociclib at Kaiser Permanente →
- Rimegepant at Kaiser Permanente →
- Risankizumab at Kaiser Permanente →
- Rituximab at Kaiser Permanente →
- Rivaroxaban at Kaiser Permanente →
- Sacubitril Valsartan at Kaiser Permanente →
- Secukinumab at Kaiser Permanente →
- Semaglutide at Kaiser Permanente →
- Sofosbuvir at Kaiser Permanente →
- Tafamidis at Kaiser Permanente →
- Tenofovir Alafenamide at Kaiser Permanente →
- Tezepelumab at Kaiser Permanente →
- Tirzepatide at Kaiser Permanente →
- Tofacitinib at Kaiser Permanente →
- Trastuzumab at Kaiser Permanente →
- Upadacitinib at Kaiser Permanente →
- Ustekinumab at Kaiser Permanente →
Generate a Kaiser Permanente PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Kaiser Permanente's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com